Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chubb
US Department of Justice
QuintilesIMS
Federal Trade Commission
US Army
Harvard Business School
Cipla
Colorcon

Generated: June 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: daclatasvir dihydrochloride

« Back to Dashboard

daclatasvir dihydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Bristol-myers Squibb DAKLINZA daclatasvir dihydrochloride TABLET;ORAL 206843 NDA E.R. Squibb & Sons, L.L.C. N 0003-0011-01
Bristol-myers Squibb DAKLINZA daclatasvir dihydrochloride TABLET;ORAL 206843 NDA E.R. Squibb & Sons, L.L.C. N 0003-0213-01
Bristol-myers Squibb DAKLINZA daclatasvir dihydrochloride TABLET;ORAL 206843 NDA E.R. Squibb & Sons, L.L.C. N 0003-0215-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Teva
Cantor Fitzgerald
Cerilliant
UBS
Covington
Mallinckrodt
Deloitte